dchen	10.3109/00498254.2013.791004	<http://dx.doi.org/10.3109/00498254.2013.791004>; rel="canonical", <http://www.tandfonline.com/doi/pdf/10.3109/00498254.2013.791004>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.3109/00498254.2013.791004"><j.0:publisher>Informa UK Limited</j.0:publisher><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/robert-l-walsky-3djpe1e84rbs5"><j.3:name>Robert L. Walsky</j.3:name><j.3:familyName>Walsky</j.3:familyName><j.3:givenName>Robert L.</j.3:givenName></j.3:Person></j.0:creator><j.2:doi>10.3109/00498254.2013.791004</j.2:doi><owl:sameAs rdf:resource="doi:10.3109/00498254.2013.791004"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/amit-s-kalgutkar-3djpe1e84rbs5"><j.3:name>Amit S. Kalgutkar</j.3:name><j.3:familyName>Kalgutkar</j.3:familyName><j.3:givenName>Amit S.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>963</j.2:pageStart><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/danny-chen-3djpe1e84rbs5"><j.3:name>Danny Chen</j.3:name><j.3:familyName>Chen</j.3:familyName><j.3:givenName>Danny</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/theunis-c-goosen-3djpe1e84rbs5"><j.3:name>Theunis C. Goosen</j.3:name><j.3:familyName>Goosen</j.3:familyName><j.3:givenName>Theunis C.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/kosea-s-frederick-3djpe1e84rbs5"><j.3:name>Kosea S. Frederick</j.3:name><j.3:familyName>Frederick</j.3:familyName><j.3:givenName>Kosea S.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/james-r-gosset-3djpe1e84rbs5"><j.3:name>James R. Gosset</j.3:name><j.3:familyName>Gosset</j.3:familyName><j.3:givenName>James R.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/mark-a-west-3djpe1e84rbs5"><j.3:name>Mark A. West</j.3:name><j.3:familyName>West</j.3:familyName><j.3:givenName>Mark A.</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>43</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/omar-l-francone-3djpe1e84rbs5"><j.3:name>Omar L. Francone</j.3:name><j.3:familyName>Francone</j.3:familyName><j.3:givenName>Omar L.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/renato-j-scialis-3djpe1e84rbs5"><j.3:name>Renato J. Scialis</j.3:name><j.3:familyName>Scialis</j.3:familyName><j.3:givenName>Renato J.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/charles-j-rotter-3djpe1e84rbs5"><j.3:name>Charles J. Rotter</j.3:name><j.3:familyName>Rotter</j.3:familyName><j.3:givenName>Charles J.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/manthena-v-varma-3djpe1e84rbs5"><j.3:name>Manthena V. Varma</j.3:name><j.3:familyName>Varma</j.3:familyName><j.3:givenName>Manthena V.</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0049-8254"><j.1:issn>1366-5928</j.1:issn><j.2:issn>1366-5928</j.2:issn><owl:sameAs>urn:issn:1366-5928</owl:sameAs><owl:sameAs>urn:issn:0049-8254</owl:sameAs><j.0:title>Xenobiotica</j.0:title><j.1:issn>0049-8254</j.1:issn><j.2:issn>0049-8254</j.2:issn></j.2:Journal></j.0:isPartOf><j.1:endingPage>972</j.1:endingPage><j.1:doi>10.3109/00498254.2013.791004</j.1:doi><j.2:pageEnd>972</j.2:pageEnd><j.0:title>Elucidation of the biochemical basis for a clinical drug–drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778 875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha</j.0:title><owl:sameAs rdf:resource="info:doi/10.3109/00498254.2013.791004"/><j.0:identifier>10.3109/00498254.2013.791004</j.0:identifier><j.2:volume>43</j.2:volume><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2013-04-30</j.0:date><j.1:startingPage>963</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/steven-g-terra-3djpe1e84rbs5"><j.3:name>Steven G. Terra</j.3:name><j.3:familyName>Terra</j.3:familyName><j.3:givenName>Steven G.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/bo-feng-3djpe1e84rbs5"><j.3:name>Bo Feng</j.3:name><j.3:familyName>Feng</j.3:familyName><j.3:givenName>Bo</j.3:givenName></j.3:Person></j.0:creator></rdf:Description></rdf:RDF>
